Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dilapan-S is a synthetic osmotic cervical dilator composed of Aquacryl, a patented hydrogel material. It is used for cervical ripening and induction of labor. The device consists of small, matchstick-sized rods that are inserted into the cervical canal. Its mechanism of action is purely mechanical and non-pharmacological; the rods absorb fluid from the surrounding cervical tissue, causing them to expand and exert radial pressure. This process gradually dilates the cervix and promotes softening (ripening) by dehydrating the tissue. It is often used as an alternative to hormonal methods like prostaglandins, particularly in cases where pharmacological induction is contraindicated or has failed. The device was evaluated by the South Warwickshire NHS Foundation Trust in the PRODUCT trial as a second-line option for labor induction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dilapan-S.